Titan Pharmaceuticals
TTNP
#10932
Rank
NZ$10.4 M
Marketcap
NZ$7.82
Share price
-3.76%
Change (1 day)
16.71%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$7.99 Million, an increase over its 2023 earnings that were of -NZ$9.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-40.8%
2024 -NZ$7.99 Million-15.5%
2023 -NZ$9.45 Million-45.43%
2022 -NZ$17.32 Million16.29%
2021 -NZ$14.9 Million-907.36%
2020 NZ$1.84 M-106.6%
2019 -NZ$27.93 Million82.4%
2018 -NZ$15.31 Million-36.93%
2017 -NZ$24.28 Million-378.62%
2016 NZ$8.71 M-145.53%
2015 -NZ$19.14 Million369.37%
2014 -NZ$4.08 Million-125.9%
2013 NZ$15.74 M-177.74%
2012 -NZ$20.25 Million13.59%
2011 -NZ$17.83 Million74.37%
2010 -NZ$10.23 Million3.61%
2009 -NZ$9.87 Million
2007 -NZ$31.28 Million12.08%
2006 -NZ$27.91 Million-28.65%
2005 -NZ$39.12 Million-10.03%
2004 -NZ$43.48 Million-6.08%
2003 -NZ$46.29 Million-14.76%
2002 -NZ$54.3 Million32.52%
2001 -NZ$40.98 Million27.55%
2000 -NZ$32.13 Million62.5%
1999 -NZ$19.77 Million4.04%
1998 -NZ$19.01 Million49.33%
1997 -NZ$12.73 Million-27.88%
1996 -NZ$17.65 Million13.04%
1995 -NZ$15.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.07 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.78 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-NZ$0.28 Billion 5,617.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-2,882.64%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.88 Million 317.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.53 Billion 10,918.25%๐Ÿ‡บ๐Ÿ‡ธ USA